Pharmacokinetic-pharmacodynamic Assessment of Seresis® in Healthy Volunteers
NCT02191787 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2014-07-17
Summary
Study to determine the antioxidant potency of Seresis® in the serum of healthy volunteers and the optimal time for blood sampling
Conditions
- Healthy
Interventions
- DRUG
-
Seresis®
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1998-03-31
- Primary Completion
- 1998-05-31
More Related Trials
-
Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers
NCT02393950 ·Status: COMPLETED ·Phase: PHASE1
-
A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males
NCT04183517 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers
NCT05830799 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function
NCT00418626 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants
NCT06309394 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance, Pharmacokinetics, Biotransformation and Bioavailability Study of ODM-201 in Healthy Male Subjects
NCT02418650 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Bosentan on the Pharmacokinetics of Nintedanib
NCT02667704 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Cenerimod in Healthy Male Subjects
NCT02914223 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance and Metabolism Study of 14C-Z-215
NCT02618629 ·Status: COMPLETED ·Phase: PHASE1
-
A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions
NCT00773630 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196
NCT04867941 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects
NCT02264054 ·Status: COMPLETED ·Phase: PHASE1
-
Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male Subjects
NCT05238714 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants
NCT07250633 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment
NCT04634149 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body
NCT03654170 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
NCT03500627 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04536961 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930
NCT03034486 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
NCT07231029 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)
NCT01465412 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of CXB909 in Healthy Male Subjects
NCT01505907 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants
NCT05981963 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects
NCT02059590 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.
NCT06258746 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1